The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 16,408 | 3,418,279 | SH | SOLE | 3,418,279 | 0 | 0 | ||
| AFFIMED NV | COM | N01045108 | 8,147 | 1,030,004 | SH | SOLE | 1,030,004 | 0 | 0 | ||
| APPLIED GENETIC TECHNOLOGIES | COM | 03820J100 | 910 | 179,511 | SH | SOLE | 179,511 | 0 | 0 | ||
| AMRYT PHARMA LTD | SPONSORED ADS | 03217L106 | 35,156 | 2,523,728 | SH | SOLE | 2,523,728 | 0 | 0 | ||
| ANGION BIOMEDICA CORP | COM | 03476J107 | 2,439 | 134,984 | SH | SOLE | 134,984 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 7,983 | 1,448,868 | SH | SOLE | 1,448,868 | 0 | 0 | ||
| APTEVO THERAPEUTICS INC | COM NEW | 03835L207 | 1,178 | 38,593 | SH | SOLE | 38,593 | 0 | 0 | ||
| AYTU BIOPHARMA INC | COM NEW | 054754874 | 2,758 | 362,910 | SH | SOLE | 362,910 | 0 | 0 | ||
| BRAINSWAY LTD | SPONSORED ADS | 10501L106 | 498 | 55,181 | SH | SOLE | 55,181 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 12,349 | 2,450,193 | SH | SOLE | 2,450,193 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | 1,564 | 109,081 | SH | SOLE | 109,081 | 0 | 0 | ||
| CONFORMIS INC | COM | 20717E101 | 4,387 | 4,431,807 | SH | SOLE | 4,431,807 | 0 | 0 | ||
| CONTRAFECT CORP | COM NEW | 212326300 | 1,292 | 269,101 | SH | SOLE | 269,101 | 0 | 0 | ||
| CHIASMA INC | COM | 16706W102 | 15,463 | 4,940,273 | SH | SOLE | 4,940,273 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 974 | 316,279 | SH | SOLE | 316,279 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 9,584 | 3,293,419 | SH | SOLE | 3,293,419 | 0 | 0 | ||
| DIAMEDICA THERAPEUTICS INC | COM NEW | 25253X207 | 9,364 | 1,023,409 | SH | SOLE | 1,023,409 | 0 | 0 | ||
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 3,344 | 329,130 | SH | SOLE | 329,130 | 0 | 0 | ||
| GALAPAGOS NV | SPON ADR | 36315X101 | 771 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| GAMIDA CELL LTD | SHS | M47364100 | 1,978 | 244,515 | SH | SOLE | 244,515 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 5,409 | 875,180 | SH | SOLE | 875,180 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 10,849 | 422,310 | SH | SOLE | 422,310 | 0 | 0 | ||
| ONCOSEC MEDICAL INC | COM | 68234L306 | 452 | 94,783 | SH | SOLE | 94,783 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 9,982 | 2,483,059 | SH | SOLE | 2,483,059 | 0 | 0 | ||
| PLX PHARMA INC | COM | 72942A107 | 4,572 | 506,274 | SH | SOLE | 506,274 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 1,230 | 445,701 | SH | SOLE | 445,701 | 0 | 0 | ||
| EXAGEN INC | COM | 30068X103 | 3,343 | 191,006 | SH | SOLE | 191,006 | 0 | 0 | ||
| XOMA CORP | COM NEW | 98419J206 | 6,663 | 163,266 | SH | SOLE | 163,266 | 0 | 0 | ||
| YUMANITY THERAPEUTICS INC | COM | 98872L102 | 6,077 | 335,745 | SH | SOLE | 335,745 | 0 | 0 | ||